ATE492532T1 - Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetik - Google Patents
Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetikInfo
- Publication number
- ATE492532T1 ATE492532T1 AT05716336T AT05716336T ATE492532T1 AT E492532 T1 ATE492532 T1 AT E492532T1 AT 05716336 T AT05716336 T AT 05716336T AT 05716336 T AT05716336 T AT 05716336T AT E492532 T1 ATE492532 T1 AT E492532T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- peptide
- acids
- arylakylic
- cosmetics
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 5
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000000863 peptide conjugate Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04007282 | 2004-03-26 | ||
| PCT/EP2005/003116 WO2005092850A1 (en) | 2004-03-26 | 2005-03-23 | Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE492532T1 true ATE492532T1 (de) | 2011-01-15 |
Family
ID=34962036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05716336T ATE492532T1 (de) | 2004-03-26 | 2005-03-23 | Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetik |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20080234344A1 (de) |
| EP (1) | EP1737819B1 (de) |
| JP (1) | JP2007530488A (de) |
| KR (1) | KR101228239B1 (de) |
| CN (1) | CN1934080A (de) |
| AT (1) | ATE492532T1 (de) |
| DE (1) | DE602005025464D1 (de) |
| ES (1) | ES2355571T3 (de) |
| WO (1) | WO2005092850A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1926703B1 (de) * | 2005-09-20 | 2013-01-09 | DSM IP Assets B.V. | Neue dicarbonsäurederivate |
| ITMI20061219A1 (it) * | 2006-06-23 | 2007-12-24 | Flamma Spa | Composti dipeptidici contenenti d-istidina |
| JP2010053099A (ja) * | 2008-08-29 | 2010-03-11 | Hamari Chemicals Ltd | しわ改善剤 |
| US20100158829A1 (en) * | 2008-12-24 | 2010-06-24 | Conopco, Inc., D/B/A Unilever | Method and Composition for Color Modulation |
| FR2981932B1 (fr) * | 2011-10-27 | 2014-10-31 | Seppic Sa | Nouveaux esters de derives n-acyles d'acides amines et de diols, procede pour leur preparation, et utilisation en cosmetique et comme medicament |
| WO2017093093A1 (en) * | 2015-11-30 | 2017-06-08 | Dsm Ip Assets B.V. | Phosphinic peptide derivatives for use as mmp-12 inhibitors |
| KR101948238B1 (ko) * | 2016-08-19 | 2019-02-14 | (주)케어젠 | 미녹시딜과 펩타이드의 결합체 |
| CN113307851B (zh) * | 2021-06-11 | 2022-04-29 | 珠海医美企业管理有限公司 | 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用 |
| KR102394709B1 (ko) * | 2021-11-30 | 2022-05-06 | (주)젠퓨어 | 신규 유사 세라마이드 화합물 및 이의 제조방법 |
| KR102816096B1 (ko) * | 2022-01-17 | 2025-06-12 | 종근당건강 주식회사 | 피부 항노화 및 보습용 식품 조성물 및 화장료 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH634662A5 (de) * | 1976-05-28 | 1983-02-15 | Pentapharm Ag | Verwendung von tripeptidderivaten zur quantitativen bestimmung von plasminogen-aktivatoren. |
| JPS6137764A (ja) * | 1984-07-31 | 1986-02-22 | Suntory Ltd | 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物 |
| US4873342A (en) * | 1985-04-16 | 1989-10-10 | Suntory Limited | Dipeptide derivative and synthesis and use thereof |
| JPH0629229B2 (ja) * | 1987-11-05 | 1994-04-20 | サントリー株式会社 | システインプロティナーゼ阻害剤 |
| JPH0832704B2 (ja) * | 1987-11-30 | 1996-03-29 | キッセイ薬品工業株式会社 | プロリルエンドペプチダーゼ阻害剤 |
| JP2674703B2 (ja) * | 1988-05-30 | 1997-11-12 | サントリー株式会社 | 新規チアゾリジン誘導体及びその用途 |
| US5236825A (en) * | 1989-01-17 | 1993-08-17 | Scripps Clinic And Research Foundation | Polyvalent metal ion-containing antibody combining site catalysts |
| CA2036398C (en) * | 1990-02-23 | 2000-06-13 | Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee | Hiv protease inhibiting agents |
| US5648337A (en) * | 1990-07-03 | 1997-07-15 | Bio-Mega/Boehringer Ingelheim Research Inc. | Antiherpes pentapeptides |
| JPH07108897B2 (ja) * | 1990-07-27 | 1995-11-22 | 日本たばこ産業株式会社 | 新規なプロリン誘導体 |
| US5936065A (en) * | 1993-12-06 | 1999-08-10 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| US5663148A (en) * | 1994-07-12 | 1997-09-02 | Abbott Laboratories | Anaphylatoxin receptor ligands containing lipophilic residues |
| US6159938A (en) * | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
| US5985242A (en) * | 1995-10-27 | 1999-11-16 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
| FR2741076B1 (fr) * | 1995-11-15 | 1998-01-30 | Rech De Pathologie Appliquee S | Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant |
| FR2741075B1 (fr) * | 1995-11-15 | 1998-01-30 | Rech De Pathologie Appliquee S | Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant |
| JP2004532200A (ja) * | 2001-03-15 | 2004-10-21 | サエジス ファーマシューティカルズ， インコーポレイテッド | 全身性ストレスの後に認識機能を回復するための方法 |
| AU2004278748B2 (en) * | 2003-09-29 | 2008-09-11 | The Regents Of The University Of California | Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
-
2005
- 2005-03-23 ES ES05716336T patent/ES2355571T3/es not_active Expired - Lifetime
- 2005-03-23 AT AT05716336T patent/ATE492532T1/de not_active IP Right Cessation
- 2005-03-23 KR KR1020067019730A patent/KR101228239B1/ko not_active Expired - Fee Related
- 2005-03-23 JP JP2007504355A patent/JP2007530488A/ja active Pending
- 2005-03-23 WO PCT/EP2005/003116 patent/WO2005092850A1/en not_active Ceased
- 2005-03-23 EP EP05716336A patent/EP1737819B1/de not_active Expired - Lifetime
- 2005-03-23 DE DE602005025464T patent/DE602005025464D1/de not_active Expired - Lifetime
- 2005-03-23 US US10/593,484 patent/US20080234344A1/en not_active Abandoned
- 2005-03-23 CN CNA2005800094864A patent/CN1934080A/zh active Pending
-
2009
- 2009-11-27 US US12/591,663 patent/US20100099727A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007530488A (ja) | 2007-11-01 |
| CN1934080A (zh) | 2007-03-21 |
| DE602005025464D1 (de) | 2011-02-03 |
| KR20070012373A (ko) | 2007-01-25 |
| EP1737819B1 (de) | 2010-12-22 |
| WO2005092850A1 (en) | 2005-10-06 |
| KR101228239B1 (ko) | 2013-01-30 |
| EP1737819A1 (de) | 2007-01-03 |
| ES2355571T3 (es) | 2011-03-29 |
| US20080234344A1 (en) | 2008-09-25 |
| US20100099727A1 (en) | 2010-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03010210A (es) | Peptidos y moleculas relacionadas que se enlazan a tall-1. | |
| Bolm et al. | Synthesis of pseudopeptides with sulfoximines as chiral backbone modifying elements | |
| DE602005025464D1 (de) | Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetik | |
| EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
| RU2003105464A (ru) | Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов | |
| BR0317268A (pt) | Compostos ativadores da pirazina e da piridina glucoquinase 5-substituìda, composição farmacêutica, uso e processo de preparação dos mesmos | |
| CY1112053T1 (el) | Συνθεση ενωσεων βορονικων εστερων και οξεων | |
| EE200200070A (et) | Raku adhesiooni inhibiitorid | |
| CY1113684T1 (el) | Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη | |
| RU95109920A (ru) | Производные гидроксамовой кислоты в качестве ингибиторов металлопротеиназы | |
| DK2369005T3 (da) | Biologisk aktive proteiner med forøget stabilitet in vivo og/eller in vitro | |
| DE3484691D1 (de) | Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE502007003887D1 (de) | Polyurethanzusammensetzung mit guter anfangsfestigkeit | |
| AR024364A1 (es) | Una composicion cosmetica para el adelgazamiento a base l-arginina, de un analogo de l-arginina, o de uno de sus derivados, que se administra por viatopica | |
| ATE480568T1 (de) | Verbesserte sgp 130fc dimere | |
| BRPI0508464B8 (pt) | sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos | |
| EA201100802A1 (ru) | Синтез пептидов с использованием энзиматической активации и конденсации | |
| BRPI0609783A8 (pt) | composto, utilização do mesmo, composição farmacêutica ou cosmética, e, utilização cosmética de um composto | |
| ATE433458T1 (de) | Modulatoren von ship-1 | |
| PT1226160E (pt) | Novos peptidos antiarritmicos | |
| BRPI0506148A (pt) | preparação farmacêutica para o tratamento de choque | |
| ATE493110T1 (de) | Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran | |
| DE69612205D1 (de) | Verfahren zur Kupplung von Polysacchariden und Proteinen | |
| ATE416259T1 (de) | Fluoreszenzbasierende kinetische bestimmung der aktivität von transglutaminasen | |
| KR970706835A (ko) | 위장 손상의 심각도의 감소 방법(Method for Reducing The Severity of Gastro-Intestinal Damage) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |